124
Views
4
CrossRef citations to date
0
Altmetric
ORIGINAL RESEARCH

Elevated ALCAM Expression Associated with Endotypes and Postoperative Recurrence in Chronic Rhinosinusitis with Nasal Polyps

, , , , & ORCID Icon
Pages 1063-1077 | Published online: 15 Feb 2022

References

  • Bachert C, Marple B, Schlosser RJ, et al. Adult chronic rhinosinusitis. Nat Rev Dis Primers. 2020;6(1):86. doi:10.1038/s41572-020-00218-1
  • Xu X, Reitsma S, Wang Y, Fokkens WJ. Highlights in the advances of chronic rhinosinusitis. Allergy. 2021;76(11):3349–3358. doi:10.1111/all.14892
  • Hopkins C. Chronic rhinosinusitis with nasal polyps. N Engl J Med. 2019;381(1):55–63. doi:10.1056/NEJMcp1800215
  • Kariyawasam HH. Chronic rhinosinusitis with nasal polyps: insights into mechanisms of disease from emerging biological therapies. Expert Rev Clin Immunol. 2019;15(1):59–71. doi:10.1080/1744666X.2019.1541738
  • Cho SH, Hamilos DL, Han DH, Laidlaw TM. Phenotypes of chronic rhinosinusitis. J Allergy Clin Immunol Pract. 2020;8(5):1505–1511. doi:10.1016/j.jaip.2019.12.021
  • McCormick JP, Thompson HM, Cho DY, Woodworth BA, Grayson JW. Phenotypes in chronic rhinosinusitis. Curr Allergy Asthma Rep. 2020;20(7):20. doi:10.1007/s11882-020-00916-6
  • Delemarre T, Bochner BS, Simon HU, Bachert C. Rethinking neutrophils and eosinophils in chronic rhinosinusitis. J Allergy Clin Immunol. 2021;148(2):327–335. doi:10.1016/j.jaci.2021.03.024
  • Bochner BS, Stevens WW. Biology and function of eosinophils in chronic rhinosinusitis with or without nasal polyps. Allergy Asthma Immunol Res. 2021;13(1):8–22. doi:10.4168/aair.2021.13.1.8
  • Lou H, Zhang N, Bachert C, Zhang L. Highlights of eosinophilic chronic rhinosinusitis with nasal polyps in definition, prognosis, and advancement. Int Forum Allergy Rhinol. 2018;8(11):1218–1225. doi:10.1002/alr.22214
  • Ho J, Hamizan AW, Alvarado R, Rimmer J, Sewell WA, Harvey RJ. Systemic predictors of eosinophilic chronic rhinosinusitis. Am J Rhinol Allergy. 2018;32(4):252–257. doi:10.1177/1945892418779451
  • Sulaj A, Kopf S, Gröne E, et al. ALCAM a novel biomarker in patients with type 2 diabetes mellitus complicated with diabetic nephropathy. J Diabetes Complicat. 2017;31(6):1058–1065. doi:10.1016/j.jdiacomp.2017.01.002
  • Ferragut F, Vachetta VS, Troncoso MF, Rabinovich GA, Elola MT. ALCAM/CD166: a pleiotropic mediator of cell adhesion, stemness and cancer progression. Cytokine Growth Factor Rev. 2021;61:27–37. doi:10.1016/j.cytogfr.2021.07.001
  • Kim YS, Kim MN, Lee KE, et al. Activated leucocyte cell adhesion molecule (ALCAM/CD166) regulates T cell responses in a murine model of food allergy. Clin Exp Immunol. 2018;192(2):151–164. doi:10.1111/cei.13104
  • Oh MS, Hong JY, Kim MN, et al. Activated leukocyte cell adhesion molecule modulates Th2 immune response in atopic dermatitis. Allergy Asthma Immunol Res. 2019;11(5):677–690. doi:10.4168/aair.2019.11.5.677
  • von Lersner A, Droesen L, Zijlstra A. Modulation of cell adhesion and migration through regulation of the immunoglobulin superfamily member ALCAM/CD166. Clin Exp Metastasis. 2019;36(2):87–95. doi:10.1007/s10585-019-09957-2
  • Semitekolou M, Xanthou G. Activated leukocyte cell adhesion molecule: a novel regulator of allergic inflammation in the airways. Am J Respir Crit Care Med. 2018;197(8):973–975. doi:10.1164/rccm.201801-0196ED
  • Kim MN, Hong JY, Shim DH, et al. Activated leukocyte cell adhesion molecule stimulates the T-cell response in allergic asthma. Am J Respir Crit Care Med. 2018;197(8):994–1008. doi:10.1164/rccm.201703-0532OC
  • Xie S, Zhang H, Wang F, et al. Activated leukocyte cell adhesion molecule as a biomarker for disease severity and efficacy of sublingual immunotherapy in allergic rhinitis. Int Immunopharmacol. 2020;88:106975. doi:10.1016/j.intimp.2020.106975
  • Fokkens WJ, Lund VJ, Mullol J, et al. EPOS 2012: European position paper on rhinosinusitis and nasal polyps 2012. A summary for otorhinolaryngologists. Rhinology. 2012;50(1):1–12. doi:10.4193/Rhino12.000
  • Zhong B, Yuan T, Du J, et al. The role of preoperative blood eosinophil counts in distinguishing chronic rhinosinusitis with nasal polyps phenotypes. Int Forum Allergy Rhinol. 2021;11(1):16–23. doi:10.1002/alr.22636
  • Xie S, Zhang H, Liu Y, et al. The role of serum metabolomics in distinguishing chronic rhinosinusitis with nasal polyp phenotypes. Front Mol Neurosci. 2020;7:593976. doi:10.3389/fmolb.2020.593976
  • Qi S, Yan B, Liu C, Wang C, Zhang L. Predictive significance of Charcot-Leyden Crystal mRNA levels in nasal brushing for nasal polyp recurrence. Rhinology. 2020;58(2):166–174. doi:10.4193/Rhin19.296
  • Brescia G, Barion U, Zanotti C, Giacomelli L, Martini A, Marioni G. The prognostic role of serum eosinophil and basophil levels in sinonasal polyposis. Int Forum Allergy Rhinol. 2017;7(3):261–267. doi:10.1002/alr.21885
  • Lu PC, Lee TJ, Huang CC, Chang PH, Chen YW, Fu CH. Serum eosinophil cationic protein: a prognostic factor for early postoperative recurrence of nasal polyps. Int Forum Allergy Rhinol. 2021;11(4):766–772. doi:10.1002/alr.22664
  • Meng Y, Zhang L, Lou H, Wang C. Predictive value of computed tomography in the recurrence of chronic rhinosinusitis with nasal polyps. Int Forum Allergy Rhinol. 2019;9(11):1236–1243. doi:10.1002/alr.22355
  • Mueller SK, Wendler O, Nocera A, et al. Escalation in mucus cystatin 2, pappalysin-A, and periostin levels over time predict need for recurrent surgery in chronic rhinosinusitis with nasal polyps. Int Forum Allergy Rhinol. 2019;9(10):1212–1219. doi:10.1002/alr.22407
  • Ma Y, Zheng C, Shi L. The role of YKL40 in the pathogenesis of CRS with nasal polyps. Eur Arch Oto-Rhino-Laryngol. 2018;275(2):431–438. doi:10.1007/s00405-017-4859-2
  • Wang XZ, Wan Z, Xue WJ, Zheng J, Li Y, Ding CG. B-cell activating factor predicts acute rejection risk in kidney transplant recipients: a 6-month follow-up study. Front Immunol. 2019;10:1046. doi:10.3389/fimmu.2019.01046
  • Yang Y, Ma Y, Gao H, et al. A novel HDGF-ALCAM axis promotes the metastasis of Ewing sarcoma via regulating the GTPases signaling pathway. Oncogene. 2021;40(4):731–745. doi:10.1038/s41388-020-01485-8
  • Münsterberg J, Loreth D, Brylka L, et al. ALCAM contributes to brain metastasis formation in non-small-cell lung cancer through interaction with the vascular endothelium. Neuro-Oncology. 2020;22(7):955–966. doi:10.1093/neuonc/noaa028
  • Zarghami N, Soto MS, Perez-Balderas F, et al. A novel molecular magnetic resonance imaging agent targeting activated leukocyte cell adhesion molecule as demonstrated in mouse brain metastasis models. J Cereb Blood Flow Metab. 2021;41(7):1592–1607. doi:10.1177/0271678X20968943
  • Darvishi B, Boroumandieh S, Majidzadeh AK, Salehi M, Jafari F, Farahmand L. The role of activated leukocyte cell adhesion molecule (ALCAM) in cancer progression, invasion, metastasis and recurrence: a novel cancer stem cell marker and tumor-specific prognostic marker. Exp Mol Pathol. 2020;115:104443. doi:10.1016/j.yexmp.2020.104443
  • Michel L, Grasmuck C, Charabati M, et al. Activated leukocyte cell adhesion molecule regulates B lymphocyte migration across central nervous system barriers. Sci Transl Med. 2019;11(518). doi:10.1126/scitranslmed.aaw0475
  • Ding H, Lin C, Cai J, et al. Urinary activated leukocyte cell adhesion molecule as a novel biomarker of lupus nephritis histology. Arthritis Res Ther. 2020;22(1):122. doi:10.1186/s13075-020-02209-9
  • Yılmaz İ. Type 2 chronic rhinosinusitis with nasal polyps: from phenotype to endotype. J Allergy Clin Immunol Pract. 2021;9(1):600–601. doi:10.1016/j.jaip.2020.11.009
  • Heffler E, Malvezzi L, Boita M, et al. Immunological mechanisms underlying chronic rhinosinusitis with nasal polyps. Expert Rev Clin Immunol. 2018;14(9):731–737. doi:10.1080/1744666X.2018.1512407
  • Toro MDC, Antonio MA, Alves Dos Reis MG, de Assumpcao MS, Sakano E. Achieving the best method to classify Eosinophilic Chronic Rhinosinusitis: a systematic review. Rhinology. 2021;59(4):330–339. doi:10.4193/Rhin20.512
  • Sella GCP, Tamashiro E, Sella JA, et al. Asthma Is the Dominant Factor for Recurrence in Chronic Rhinosinusitis. J Allergy Clin Immunol Pract. 2020;8(1):302–309. doi:10.1016/j.jaip.2019.08.007
  • Du K, Zheng M, Zhao Y, et al. A nomogram combing peripheral parameters for estimation of CRSwNP recurrence. Am J Rhinol Allergy. 2021;35:578–586.
  • Brescia G, Contro G, Giacomelli L, Barion U, Frigo AC, Marioni G. Blood eosinophilic and basophilic trends in recurring and non-recurring eosinophilic rhinosinusitis with nasal polyps. Am J Rhinol Allergy. 2021;35(3):296–301. doi:10.1177/1945892420953960
  • Hong SN, Kim YS, Cha H, et al. Endotype-related recurrence pattern of chronic rhinosinusitis in revision functional endoscopic sinus surgery. Auris Nasus Larynx. 2021. doi:10.1016/j.anl.2021.07.010
  • Hopkins C, Lund V. Does time from previous surgery predict subsequent treatment failure in chronic rhinosinusitis with nasal polyps? Rhinology. 2021;59(3):277–283. doi:10.4193/Rhin21.017
  • Bayar Muluk N, Cingi C, Scadding GK, Scadding G. Chronic rhinosinusitis-could phenotyping or endotyping aid therapy? Am J Rhinol Allergy. 2019;33(1):83–93. doi:10.1177/1945892418807590
  • Avdeeva K, Fokkens W. Precision medicine in chronic rhinosinusitis with nasal polyps. Curr Allergy Asthma Rep. 2018;18(4):25. doi:10.1007/s11882-018-0776-8